Mary Kay Fenton, executive vice president and chief financial officer of Achillion Pharmaceuticals Inc., and Ken Hiscoe, director of U.S. government and corporate affairs for Pfizer Inc., have been appointed co-chairs of CBIA’s Connecticut Bioscience Growth Council.
The council’s mission is to grow Connecticut’s bioscience sector.
At Achillion, Fenton oversees financial strategy development and capital formation, financial reporting and compliance, and treasury and tax functions. She also oversees operating functions such as risk management, legal compliance, facilities management, purchasing, and information technology. Prior to joining Achillion, Fenton was responsible for life sciences clients in Connecticut and western New York with the Technology Industry Group at PricewaterhouseCoopers where she advised fast-growing bioscience and technology companies on initial public offerings and other SEC matters, mergers and acquisitions, and strategic alliances.
Hiscoe joined Pfizer in 2007 as director of public affairs at Pfizer’s worldwide research and development headquarters in Groton and worked in Pfizer’s New York City headquarters as director of political affairs. Before joining Pfizer, Hiscoe served as district director and senior adviser to Congresswoman Nancy Johnson.
